123 related articles for article (PubMed ID: 28752901)
1. Pegaspargase-induced hypertriglyceridemia.
Shmookler A; Smith S
J Clin Apher; 2018 Feb; 33(1):97-98. PubMed ID: 28752901
[No Abstract] [Full Text] [Related]
2. Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia.
Lau KM; Saunders IM; Goodman A
J Oncol Pharm Pract; 2020 Jan; 26(1):193-199. PubMed ID: 30823860
[TBL] [Abstract][Full Text] [Related]
3. Insulin infusion to treat severe hypertriglyceridemia associated with pegaspargase therapy: a case report.
Lawson EB; Gottschalk M; Schiff DE
J Pediatr Hematol Oncol; 2011 Mar; 33(2):e83-6. PubMed ID: 21343748
[TBL] [Abstract][Full Text] [Related]
4. Treatment of severe hypertriglyceridemia associated with accidental pegylated asparaginase push in a child with relapsed acute lymphoblastic leukemia.
Malbora B; Avci Z; Ozbek N
Drug Chem Toxicol; 2012 Oct; 35(4):463-6. PubMed ID: 22149271
[TBL] [Abstract][Full Text] [Related]
5. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia.
Solano-Páez P; Villegas JA; Colomer I; Gutierrez MD; Fernandez-Teijeiro A
J Pediatr Hematol Oncol; 2011 Apr; 33(3):e122-4. PubMed ID: 21399528
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia.
Daley RJ; Rajeeve S; Kabel CC; Pappacena JJ; Stump SE; Lavery JA; Tallman MS; Geyer MB; Park JH
Leuk Lymphoma; 2021 Jan; 62(1):176-184. PubMed ID: 32985296
[TBL] [Abstract][Full Text] [Related]
7. True hyponatremia in the setting of pegasparagase-induced hypertriglyceridemia: A case report.
Olayinka L; Poventud-Fuentes I; Rahman Ansari S; Garnett E; Devaraj S
Clin Chim Acta; 2022 Jun; 531():68-70. PubMed ID: 35283095
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Pegylated Asparaginase-Induced Hypertriglyceridemia with Continuous Intravenous Infusion of Insulin and Heparin: A Case Report.
Alakel N; Heuschkel S; Balaian E; Röllig C; Bornhäuser M
Chemotherapy; 2019; 64(4):210-214. PubMed ID: 32045924
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia.
Douer D; Aldoss I; Lunning MA; Burke PW; Ramezani L; Mark L; Vrona J; Park JH; Tallman MS; Avramis VI; Pullarkat V; Mohrbacher AM
J Clin Oncol; 2014 Mar; 32(9):905-11. PubMed ID: 24516026
[TBL] [Abstract][Full Text] [Related]
10. Successful use of palifermin following severe anaphylaxis to pegaspargase in a pediatric patient with acute lymphoblastic leukemia.
Kaminski KS; Beach CL; Peden DB; Le U; Roehrs PA
J Oncol Pharm Pract; 2016 Apr; 22(2):354-6. PubMed ID: 25567519
[TBL] [Abstract][Full Text] [Related]
11. PEG-asparaginase induced severe hypertriglyceridemia.
Galindo RJ; Yoon J; Devoe C; Myers AK
Arch Endocrinol Metab; 2016 Apr; 60(2):173-7. PubMed ID: 26331232
[TBL] [Abstract][Full Text] [Related]
12. Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses.
Burke PW; Aldoss I; Lunning MA; Devlin SM; Tallman MS; Pullarkat V; Mohrbacher AM; Douer D
Leuk Res; 2018 Mar; 66():49-56. PubMed ID: 29407583
[TBL] [Abstract][Full Text] [Related]
13. Very high hypertriglyceridemia induced: is plasmapheresis needed?
Berrueco R; Rives S; López-García VS; Catalá A; Toll T; Estella J
Pediatr Blood Cancer; 2011 Sep; 57(3):532. PubMed ID: 21618412
[No Abstract] [Full Text] [Related]
14. Toxicity study of pegaspargase.
Ettinger LJ; Lerner ED; Manglani MV
Indian Pediatr; 2000 Jun; 37(6):631-6. PubMed ID: 10869143
[No Abstract] [Full Text] [Related]
15. Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature.
Blackman A; Boutin A; Shimanovsky A; Baker WJ; Forcello N
J Oncol Pharm Pract; 2018 Jul; 24(5):393-397. PubMed ID: 28523950
[TBL] [Abstract][Full Text] [Related]
16. Allergic Reactions With Intravenous Compared With Intramuscular Pegaspargase in Children With High-risk Acute Lymphoblastic Leukemia: A Population-based Study From the Maritimes, Canada.
MacDonald T; Kulkarni K; Bernstein M; Fernandez CV
J Pediatr Hematol Oncol; 2016 Jul; 38(5):341-4. PubMed ID: 26925715
[TBL] [Abstract][Full Text] [Related]
17. Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Tozuka M; Yamauchi K; Hidaka H; Nakabayashi T; Okumura N; Katsuyama T
Ann Clin Lab Sci; 1997; 27(5):351-7. PubMed ID: 9303174
[TBL] [Abstract][Full Text] [Related]
18. Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis.
Ridola V; Buonuomo PS; Maurizi P; Putzulu R; Annunziata ML; Pietrini D; Riccardi R
Pediatr Blood Cancer; 2008 Feb; 50(2):378-80. PubMed ID: 16883590
[TBL] [Abstract][Full Text] [Related]
19. L-asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23 abnormality.
Jain S; Naithani R; Kapoor G; Nath T
Leuk Res; 2009 Nov; 33(11):e194. PubMed ID: 19487026
[No Abstract] [Full Text] [Related]
20. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]